Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germ-line mutation

被引：16
作者：
Albiero, Elena [1 ]
Ruggeri, Marco [1 ]
Fortuna, Stefania [1 ]
Bernardi, Martina [1 ]
Finotto, Silvia [1 ]
Madeo, Domenico [1 ]
Rodeghiero, Francesco [1 ]
机构：
[1] San Bortolo Hosp, Dept Cellular Therapies & Haematol, Vicenza, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 153卷 / 03期
关键词：
chronic myeloproliferative neoplasms; oxygen sensing pathway; genetic lesion; EGLN1; JAK2; JAK2; ERYTHROCYTOSIS; DISORDERS;
D O I：
10.1111/j.1365-2141.2010.08551.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：405 / 408
页数：4
相关论文
共 10 条
  • [1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [2] Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders
    Bellanne-Chantelot, Christine
    Chaumarel, Isabelle
    Labopin, Myriarn
    Bellanger, Florence
    Barbu, Veronique
    De Toma, Claudia
    Delhommeau, Frangois
    Casadevall, Nicole
    Vainchenker, William
    Thomas, Gilles
    Najman, Albert
    [J]. BLOOD, 2006, 108 (01) : 346 - 352
  • [3] Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation
    Bernardi, Martina
    Ruggeri, Marco
    Albiero, Elena
    Madeo, Domenico
    Rodeghiero, Francesco
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (04) : 258 - 260
  • [4] Molecular basis and clonal evolution of myeloproliferative neoplasms
    Jaeger, Roland
    Kralovics, Robert
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 526 - 529
  • [5] Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
    Landgren, Ola
    Goldin, Lynn R.
    Kristinsson, Sigurdur Y.
    Helgadottir, Elin A.
    Samuelsson, Jan
    Bjorkholm, Magnus
    [J]. BLOOD, 2008, 112 (06) : 2199 - 2204
  • [6] Genetic causes of erythrocytosis and the oxygen-sensing pathway
    Lee, Frank S.
    [J]. BLOOD REVIEWS, 2008, 22 (06) : 321 - 332
  • [7] Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
    Oh, Stephen T.
    Simonds, Erin F.
    Jones, Carol
    Hale, Matthew B.
    Goltsev, Yury
    Gibbs, Kenneth D., Jr.
    Merker, Jason D.
    Zehnder, James L.
    Nolan, Garry P.
    Gotlib, Jason
    [J]. BLOOD, 2010, 116 (06) : 988 - 992
  • [8] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    Tefferi, A.
    [J]. LEUKEMIA, 2010, 24 (06) : 1128 - 1138
  • [9] Vardiman JW., 2008, WHO CLASSIFICATION T
  • [10] Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains
    Villar, Diego
    Vara-Vega, Alicia
    Landazuri, Manuel O.
    Del Peso, Luis
    [J]. BIOCHEMICAL JOURNAL, 2007, 408 : 231 - 240
1